Intimacy Expert: The Masterclass On Better Sex, Orgasms & Pleasure | Dr Rachel Rubin

Why does it matter? Because the cure for painful sex, UTI deaths, and fading relationships is sitting in a $14 tube most doctors won't prescribe.

Dr. Rachel Rubin opens with three words: "I'm filled with rage." Not at patients. At a medical system that has the answers — cheap, safe, decades-tested — and still isn't using them. She's a urologist who specializes in sexual health, and this is her reckoning with what medicine has failed to teach, and what that failure costs.

• A $14 vaginal estrogen cream used twice weekly prevents UTI deaths, eliminates painful sex, and improves orgasm — yet more than 75% of women who need it aren't getting a prescription • The word "clitoris" doesn't appear anywhere in the 2026 OB/GYN training checklist — which is why 20% of women can't orgasm and virtually none have ever had the organ examined • HRT was abandoned based on a misread press conference; the original authors confirmed in 2025 it carries no cardiovascular risk below age 70 • Women's "low libido" is often responsive arousal — desire that emerges once intimacy starts — being mistaken for dysfunction by partners who only know the spontaneous kind

A $14 cream used twice a week prevents UTI deaths, fixes painful sex, and improves orgasm — and more than 75% of women who need it can't get a prescription

"It's literally better than Viagra." That's Rubin, holding up a $14 tube of estradiol cream and describing a treatment backed by medical literature going back to the 1990s.

Vaginal estrogen, rubbed into the walls of the vagina twice a week — about a gram, applied the way you'd apply sunscreen to your face — keeps the vaginal environment acidic. Acid suppresses bad bacteria. Healthy bacteria protect the bladder. When estrogen drops at menopause, during breastfeeding, or at any hormonal shift, that microbiome destabilizes. Infections rise. Tissue thins. Sex becomes painful. Urinary urgency and leakage follow. In elderly women, UTIs can progress to urosepsis, require ICU care, and kill.

Vaginal hormones prevent UTIs by more than half. They eliminate dryness. They restore arousal and improve orgasm. The same effect is available as a small tablet insert or a silicone ring that stays in place for three months. "It is safe for your great grandmother in the nursing home. It is safe for your wife who's breastfeeding." Women with cancer histories, blood clot histories, stroke histories — all candidates. The systemic absorption is negligible.

More than 75% of women in large database collections are not receiving prescriptions for this. Less than 9% of Medicare patients get it.

The barrier is not safety. Not cost. It's that doctors were scared off hormones twenty years ago and never found their way back. The result is preventable deaths, preventable pain, and relationships collapsing over a symptom that costs $14 to treat.

The word "clitoris" does not appear anywhere in the 2026 OB/GYN training checklist — and no doctor has ever examined yours

Here is a fact delivered without softening: in 2026, the specialty most responsible for women's reproductive and sexual health does not require its trainees to learn the word "clitoris." Not the anatomy. Not the clinical relevance. The word itself is absent from the checklist.

"The word clitoris today in 2026 does not exist in the checklist for what an OB/GYN has to learn in their training. The word doesn't exist."

Women come to Rubin saying they're broken. They can't orgasm, penetration produces nothing, they've never felt what they were supposed to feel. In nearly every case, what's broken is the education — not the body.

The clitoris is the primary site of female orgasm. It's a large, mostly internal structure — the visible tip is just the start — that runs toward the sit bones, engorges with blood exactly like a penis, and contracts at orgasm. Under a microscope, it's the same tissue as a penis. And yet no routine gynecological exam has ever included it. No Pap smear. No annual checkup. About 20% of women report they cannot orgasm; Rubin's interpretation is that most of them aren't broken, they're using the wrong anatomy.

When she opened her practice, she bought two mirrors on Amazon. She hands one to every patient and narrates as she examines: this is your labia majora, your labia minora, your clitoris. Women in their 40s and 50s are hearing these names for the first time. That shouldn't be a medical innovation. It's the baseline.

A misread press conference in 2003 ended hormone therapy overnight — the original authors corrected the record in 2025

In 2025, the same scientists who frightened the medical world off HRT published a correction: below age 70, that type of hormone therapy carries no increased risk of cardiovascular disease or stroke. They've known this for years. Most doctors are still operating on the 2003 version.

Here is what happened. A billion dollars of NIH funding produced the Women's Health Initiative — thousands of women, ages 50 to 79, followed for years on hormone therapy. When researchers stopped the study early, they held a press conference and made claims that weren't in the data. "Overnight, a multi-billion dollar industry went to nothing. Everyone was told throw your hormones in the garbage. This is dangerous." Physicians who had been prescribing HRT successfully were bewildered — their patients weren't developing extra heart disease, weren't getting the breast cancers the headlines described. But the fear moved faster than any correction and calcified into training programs.

A generation of doctors came up learning that hormones were dangerous. They never got the class on how to prescribe them. And so when a patient asks today, the default is still "no" — inherited from a press conference, not from evidence.

Melinda Gates saw three doctors before getting a proper HRT prescription. Oprah saw five, still had her heart palpitations misattributed. Halle Berry was diagnosed with genital herpes when she had genitourinary syndrome of menopause.

Only 1.7% of women who should be offered hormone therapy are receiving prescriptions. The fear your mother absorbed about HRT was never accurate. The evidence that cleared it has been published. Most clinicians still haven't read it.

One in four women has a treatable physical cause of orgasm difficulty that no doctor has ever looked for

About 23% of women have a clitoral adhesion — the hood stuck to the head, preventing full exposure of the organ. You should be able to pull it back. In roughly a quarter of all women, you can't.

Rubin's team published data on what happens when those adhesions are removed in a simple office procedure: improvements in orgasm, arousal, and sexual satisfaction up to 60 to 70%. Not incremental change — transformative, for a condition affecting one in four women and diagnosable in minutes.

Nobody has found it in virtually any of them. Because nobody has looked.

"No one has ever examined their clitoris, ever. In any exam, in any doctor's visit."

The cycle is infuriating in its circularity: the clitoris isn't examined because it's not in training, and it's not in training because no one decided it mattered enough to add. The result is that a quarter of women may be carrying an untreated anatomical issue — having worse orgasms, or none, attributing it to stress or age — while a five-minute procedure sits waiting unused in the research literature.

Women experiencing orgasm difficulty or unexplained changes in arousal should ask a sexual health specialist specifically for a clitoral examination. The condition is common. The fix exists. The only barrier is that no one has thought to check.

Women's testosterone starts falling in their 30s — not at menopause — and the birth control pill quietly accelerates the drop

Testosterone isn't a male hormone. It's just a hormone — and women make it in their ovaries throughout their lives. What the standard medical charts taught in training don't show is that female testosterone begins dropping precipitously not at menopause, but in the 30s. Libido dips. Orgasm takes longer. Arousal and engorgement feel different. These changes get attributed to stress or relationship friction while the biology goes unexamined.

Birth control compounds the problem directly. The combined pill suppresses the ovaries entirely. "Your ovary does three things. It does estrogen, progesterone, and testosterone. It doesn't add back testosterone." The ovaries quiet down — and testosterone disappears. Up to 27% of people on birth control report decreased libido in some studies. Steven mentions his fiancée's libido challenges resolved after coming off the pill. Rubin doesn't overclaim the cause, but the mechanism tracks precisely.

In Rubin's clinic, she gives women FDA-approved testosterone at roughly one-tenth the male dose. "Over the 3 to 6 months of taking it, they get this — it clicks." Global consensus supports testosterone for libido in postmenopausal women; evidence in younger women is building.

Not every woman needs it. But every woman noticing changes in desire or arousal in her 30s deserves a doctor who knows to check testosterone levels and ask about birth control history — rather than defaulting to "that's just stress."

Women's so-called "low libido" is usually responsive arousal — desire that emerges once intimacy starts — and partners keep waiting for the wrong signal

The dominant arousal pattern in women isn't spontaneous — it's responsive, meaning desire that doesn't arrive until intimacy is already underway. Only 10 to 15% of women experience spontaneous desire as their primary pattern. About 70% of men do.

A partner waiting for a woman to already want sex the way he does is, in most relationships, waiting for something that physiologically isn't coming. He reads her hesitation as rejection. She senses his disappointment. Both stop trying.

Rubin draws the analogy to exercise: some people walk into the gym fired up; others dread going, start anyway, and find the reluctance falls away within minutes. They don't have a gym problem. They have a different on-ramp. "Is that really low libido at all or is that sort of the product of like we just aren't talking about it improving?"

There's a second layer, less physiological and more relational: even responsive desire needs something worth responding to. "If you have sex the same way every single time and it's not that fun and it's not that interesting to your partner, are they going to look forward to it?" The label "low libido" can be a medical conclusion. More often it's a relationship conclusion disguised as one.

The practical shift is small but counterintuitive: start. Don't wait for both people to already be in the mood. Initiate gently, stay curious, and let the arousal arrive on its own schedule.

Couples turn sexual dysfunction into a "who's the bad guy" problem — and the framing destroys what biology could have saved

Sexual dysfunction doesn't announce itself as a medical event. It arrives as a feeling — distance, rejection, something quietly wrong. Feelings, in intimate relationships, become narratives. The partner with low desire becomes the one who stopped caring. The partner with frustration becomes the one who only wants one thing. Both stories feel completely real. Both are usually wrong.

Steven describes a relationship in his early 20s where his partner told him she didn't like sex. He assumed he was the problem. His closest friend's partner said the same thing. Both couples arrived at explanations that felt accurate and permanent. None of them were right.

"A little bit of information gave you empathy for this partner where you took it on as a you problem, it became a you problem cuz it was both of you together, but it started with biology."

Rubin's framework cuts through the blame: "There's no bad guy. That person has a high libido and that person has a low libido. There's no evil bad guy, but there is still conflict." The conflict is real — but its cause is usually diagnosable. Painful sex is a tissue or hormone issue. Mismatched desire is often an arousal-style difference or a treatable hormonal event. Neither is a character flaw.

Steven arrives at the reframe himself: "It was neither of us. It was really the whole time not me against her or her against me. It was me and her against the problem." That pivot — from blame to collaboration — is the one most couples never make, because no one told them the problem had a biological explanation both of them could go looking for together.

The information is the cure

Rubin describes a sex recession — people having less intimacy than ever, scrolling instead of connecting, arriving at relationships without vocabulary for their own anatomy. What she's really diagnosing is a knowledge transfer failure: the research is done, the medications are cheap, the procedures work, and almost none of it has made it from journal to clinic to the couple sitting quietly in the dark trying to figure out what went wrong between them.

The generation that receives this information will navigate their bodies and their relationships differently. And given that the primary treatment costs $14 and is available at most pharmacies, the gap between knowing and not knowing has never been cheaper to close.

The cure has been generic for decades.

---

Topics: women's health, sexual health, hormones, HRT, menopause, orgasm, clitoris, libido, testosterone, birth control, UTI, pelvic floor, sex education, intimacy, relationships, vaginal estrogen, perimenopause, arousal, sexual dysfunction